Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by stockman6on Nov 09, 2001 11:59am
842 Views
Post# 4387696

RE: Patent Issue

RE: Patent IssueSo let's talk about ISA without a patent. They are still the only company who knows how to make this molecule. They are the only company who have completed Phase 1 trials for this molecule. They are the only company conducting Phase 2 trials for this molecule. They are the only company in the process of being fast-tracked by the regulating bodies. They are literally years ahead of any competitors. If you are a major pharmacutical, it is still in your best effort to strike a deal with Isotechnical, patent or no patent, since you will be first to market by a long shot.
Bullboard Posts